Executive Vice Chairman
Jerome ‘Jerry’ Zeldis joined Immodulon in September 2017, bringing over 23 years’ experience working across a number of senior positions in the pharmaceutical industry.
He is President of Clinical Research, Drug Safety, and Regulatory, and Chief Medical Officer at Sorrento Therapeutics and, prior to this, held a number of senior positions within Celgene namely CEO of Celgene Global Heath, Chief Medical Officer, Senior Vice President of Clinical Research and Medical Affairs where he was instrumental in growing Celgene into one of the leading global biopharmaceutical companies. Prior to working at Celgene, Dr. Zeldis worked at Sandoz Research Institute and Janssen Research Institute in both clinical research and medical development. Dr. Zeldis earned an MD and PhD at Yale University, then trained in Internal Medicine at UCLA and gastroenterology at Harvard Medical School.
He has been a board member of a few start-up biotechnology companies. He has published 123 peer reviewed articles and is named as an inventor in 44 US patents.